Literature DB >> 18288557

Treatment of Graf's ultrasound class III and IV hips using Pavlik's method.

Eli Peled1, Viktor Bialik, Alexander Katzman, Mark Eidelman, Doron Norman.   

Abstract

UNLABELLED: When Pavlik introduced his method of treating congenital dislocation of the hip, he emphasized reducing the rate of osteonecrosis. Graf's method of sonographic evaluation afforded earlier accurate diagnosis and subsequent treatment of developmental dysplasia of the hip. To ascertain whether treatment duration, gender, age at diagnosis, clinical stability, and/or treatment onset correlate with the risk of osteonecrosis in Graf Type III or IV hips, we clinically and sonographically screened 18,067 neonates (36,134 hips) for developmental dysplasia of the hip over a 4-year period; 151 had Graf Type III or IV hips, and 78 of these were treated by us and had known outcomes. Of these 78 hips, 65 (0.18%) had Graf Type III and 13 (0.036%) had Graf Type IV hips. Sixteen of the 65 Type III hips (25%) reduced spontaneously. Using Pavlik's method, reduction was achieved in 46 of 65 (88.5%) Type III hips and eight of 13 Type IV hips. None of the hips treated exclusively by Pavlik's method developed osteonecrosis. Thus, the method achieves one of Pavlik's original goals of decreasing osteonecrosis incidence to close to zero. LEVEL OF EVIDENCE: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2008        PMID: 18288557      PMCID: PMC2504669          DOI: 10.1007/s11999-008-0119-5

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

Review 1.  Paediatric hip--ultrasound screening for developmental dysplasia of the hip: a review.

Authors:  P Tomà; M Valle; U Rossi; G M Brunenghi
Journal:  Eur J Ultrasound       Date:  2001-10

2.  An evaluation of conservative and operative methods in the treatment of congenital hip dislocation.

Authors:  D Tönnis
Journal:  Clin Orthop Relat Res       Date:  1976-09       Impact factor: 4.176

3.  Clinical practice guideline: early detection of developmental dysplasia of the hip. Committee on Quality Improvement, Subcommittee on Developmental Dysplasia of the Hip. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  2000-04       Impact factor: 7.124

4.  Stirrups as an aid in the treatment of congenital dysplasias of the hip in children. By Arnold Pavlik, 1950.

Authors:  A Pavlik
Journal:  J Pediatr Orthop       Date:  1989 Mar-Apr       Impact factor: 2.324

Review 5.  Developmental dysplasia of the hip from six months to four years of age.

Authors:  M G Vitale; D L Skaggs
Journal:  J Am Acad Orthop Surg       Date:  2001 Nov-Dec       Impact factor: 3.020

6.  Indicators of successful use of the Pavlik harness in infants with developmental dysplasia of the hip.

Authors:  H Atalar; U Sayli; O Y Yavuz; I Uraş; H Dogruel
Journal:  Int Orthop       Date:  2006-04-07       Impact factor: 3.075

7.  Congenital hip dysplasia in the light of early and very early diagnosis.

Authors:  M Ortolani
Journal:  Clin Orthop Relat Res       Date:  1976-09       Impact factor: 4.176

Review 8.  Congenital dislocation of the hip.

Authors:  G D MacEwen; C Millet
Journal:  Pediatr Rev       Date:  1990-02

9.  Treatment of developmental dysplasia of the hip with Pavlik harness: prospective study in Graf type IIc or more severe hips.

Authors:  D Hakan Uçar; Z Uğur Işiklar; Utku Kandemir; Yücel Tümer
Journal:  J Pediatr Orthop B       Date:  2004-03       Impact factor: 1.041

10.  Treatment of true developmental dysplasia of the hip using Pavlik's method.

Authors:  Mark Eidelman; Alexander Katzman; Shay Freiman; Eli Peled; Viktor Bialik
Journal:  J Pediatr Orthop B       Date:  2003-07       Impact factor: 1.041

View more
  14 in total

1.  Success of Pavlik Harness Treatment Decreases in Patients ≥ 4 Months and in Ultrasonographically Dislocated Hips in Developmental Dysplasia of the Hip.

Authors:  Hakan Ömeroğlu; Nusret Köse; Anil Akceylan
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  Verification of hip reduction using anterior ultrasound scanning during Pavlik harness treatment of developmental dysplasia of the hip.

Authors:  Graeme S Carlile; Timothy Woodacre; Peter J Cox
Journal:  J Orthop       Date:  2014-09-26

3.  [Pavlik harness for the treatment of congenital hip dysplasia types D III and IV].

Authors:  D Zajonz; S Strobel; M Wojan; N von der Höh; P Brandmaier; C Josten; E Schumann; C-E Heyde
Journal:  Orthopade       Date:  2016-01       Impact factor: 1.087

Review 4.  Developmental dysplasia of the hip: What has changed in the last 20 years?

Authors:  Pavel Kotlarsky; Reuben Haber; Victor Bialik; Mark Eidelman
Journal:  World J Orthop       Date:  2015-12-18

Review 5.  [Treatment recommendations for protracted hip immaturity in infants : Conservative approach versus open reduction].

Authors:  J Matussek; E Dingeldey
Journal:  Orthopade       Date:  2018-06       Impact factor: 1.087

6.  The use of X-ray at 5 months in a selective screening programme for developmental dysplasia of the hip.

Authors:  Kathryn R Price; Rosemary Dove; James B Hunter
Journal:  J Child Orthop       Date:  2011-04-01       Impact factor: 1.548

7.  Higher Pavlik Harness Treatment Failure Is Seen in Graf Type IV Ortolani-positive Hips in Males.

Authors:  Eduardo N Novais; Lauryn A Kestel; Patrick M Carry; Mariana L Meyers
Journal:  Clin Orthop Relat Res       Date:  2016-03-14       Impact factor: 4.176

8.  Treatment of the Developmental Dysplasia of the Hip with an Abduction Brace in Children up to 6 Months Old.

Authors:  Raphaël Wahlen; Pierre-Yves Zambelli
Journal:  Adv Orthop       Date:  2015-02-26

9.  Targeted Screening of Hip Dysplasia in Newborns: Experience at a District General Hospital in Scotland.

Authors:  Rahul Tyagi; Marcin R Zgoda; Rachel Short
Journal:  Orthop Rev (Pavia)       Date:  2016-09-30

10.  Open reduction for developmental dysplasia of the hip: failures of screening or failures of treatment?

Authors:  A P Sanghrajka; C F Murnaghan; A Shekkeris; D M Eastwood
Journal:  Ann R Coll Surg Engl       Date:  2013-03       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.